期刊文献+

高效液相色谱法测定富马酸沃诺拉赞的含量 被引量:3

Content Determination of Vonoprazan Fumarate by HPLC
下载PDF
导出
摘要 目的:建立富马酸沃诺拉赞的含量测定方法。方法:采用高效液相色谱法,色谱柱为Agilent TC-C_(18)柱(4.6 mm×150 mm,2.5μm),流动相为0.01 mol/L磷酸钠溶液-乙腈(V∶V=75∶25),流速为1.0 ml/min,检测波长为230 nm,进样量为10μl。结果:富马酸沃诺拉赞的线性范围是121.06~282.48μg/ml,线性方程为Y=16 019X-28 538(r=1.000 0);平均加样回收率为100.40%,RSD=0.79%(n=9);6批样品含量测定结果分别为100.2%、100.8%、100.4%、100.6%、100.0%及99.8%。结论:本方法简便、快速且准确,可用于富马酸沃诺拉赞的质量控制。 OBJECTIVE: To establish a method for content determination of vonoprazan fumarate. METHODS: HPLC method was adopted. Agilent TC-C_(18)column(4.6 mm×150 mm, 2.5 μm) was used and the mobile phase was 0.01 mol/L sodium phosphate solution-acetonitrile(V∶V=75∶25), the flow rate was 1.0 ml/min, the detection wavelength was 230 nm and the sample volume was 10 μl. RESULTS: The linear range of vonoprazan fumarate was 121.06-282.48 μg/ml, the linear equation was Y=16 019 X-28 538(r=1.000 0), the average sample recovery was 100.40%, RSD was 0.79%(n=9). The results of 6 batches of samples were 100.2%, 100.8%, 100.4%, 100.6%, 100.0% and 99.8%, respectively. CONCLUSIONS: The method is simple, fast and accurate and can be used for the quality control of vonoprazan fumarate.
作者 肖敏 乐志艳 XIAO Min;LE Zhiyan(Dept.of Quality Control,Institute for Food and Drug Control of Jiangxi Fuzhou,Jiangxi Fuzhou 344000,China)
出处 《中国医院用药评价与分析》 2018年第10期1381-1383,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 富马酸沃诺拉赞 含量测定 方法学验证 高效液相色谱法 Vonoprazan fumarate Content detemlination Methodological validation HPLC
  • 相关文献

参考文献3

二级参考文献6

  • 1Garnock-Jones KP. Vonoprazan: first global approval [J]. Drugs, 2015, 75 (4) :439--443.
  • 2Scott DR, Munson KB, Marcus EA, et al. The binding selectivity of vonoprazan(TAK-438) to the gastric H*, K+- ATPase [ J]. Aliment Pharmaeol Ther, 2015, 42 ( 11-12) : 1315--1326.
  • 3Jenkins H, Sakurai Y, Nishimura A, et al. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK- 438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects [J]. Aliment Pharmaeol Ther, 2015, 41 (7) : 636--648.
  • 4池本朋己,水船秀哉,长田敏明,等.制备吡咯化合物的方法:中国,104211618[P].2014-12-17.
  • 5棍野正博,莲冈淳,西田晴行.作为胃酸分泌抑制剂的1-杂环基磺酰基、2.氨基甲基、5.(杂)芳基取代的1-H吡咯衍生物:中国,101300229[P].2008-11-05.
  • 6余倩盈,刘育,姚凯,李建其,王冠.富马酸沃诺拉赞的合成工艺[J].中国医药工业杂志,2016,47(11):1348-1351. 被引量:9

共引文献16

同被引文献30

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部